Table 3.
Adjusted Cumulative Incidence of Primary Outcomes, by Voriconazole Exposure
| Adjusted Cumulative Incidencea
|
|||
|---|---|---|---|
| Years Post-Transplant | “Never” Voriconazole Exposure (−) | “Ever” Voriconazole Exposure (+) | Absolute Risk Difference |
| Squamous Cell Carcinoma
| |||
| 1 year | 1% | 1% | 0% |
| 5 years | 15% | 25% | + 10% |
| 10 years | 28% | 43% | + 15% |
|
| |||
|
Aspergillus Colonization
| |||
| 1 year | 28% | 15% | −13% |
| 5 years | 44% | 25% | −19% |
| 10 years | 63% | 39% | −24% |
|
| |||
| Invasive Aspergillosis
| |||
| 1 year | 10% | 8% | − 2% |
| 5 years | 22% | 18% | − 4% |
| 10 years | 27% | 21% | − 6% |
|
| |||
| All Cause Mortality
| |||
| 1 year | 7% | 8% | +1% |
| 5 years | 39% | 47% | +8% |
| 10 years | 58% | 69% | +11% |
a
Adjusted for age at transplant, sex, race, and year of transplant.